The following funding news and opportunities were collected recently by Pre-Award Services and published in Update, a weekly e-newsletter for members and staff.

Visit the Research Funding Resources page for links to resources you can use to search for funding as well as University resources essential to application processes.

November 10

Important News and Notices

Non-Competing Grant Awards under the Current Continuing Resolution
(NOT-OD-10-012)
National Institutes of Health

Funding Opportunity Announcements (non-NIH)

KWRIS Sarcoma Research Grant
The Karen Wyckoff Rein in Sarcoma Foundation
Application Receipt Date: December 11, 2009
Funding: typically ranges from $12,000 to $50,000

American Cancer Society Institutional Research Grants
Deadline: November 16, 2009
Amount: Up to $30,000
These grants are for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes genetic mechanisms of cancer, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic models and translational research, cancer immunology and immunotherapy. Applications may be obtained by calling 612-625-2912 or e-mailing morga336@umn.edu.

CALGB Investigator Award
Cancer and Leukemia Group B
Application Receipt Date(s): January 15, 2009
Eligibility: Assistant Professor faculty with 1-3 years of a faculty appointment
Funding: $30,000 + 10% overhead costs for 1 year

CALGB Clinical Scholar Award
Cancer and Leukemia Group B
Application Receipt Date(s): January 15, 2009
Eligibility: Assistant Professor faculty with 4-6 years of a faculty appointment
Funding: $40,000 + 10% overhead costs per year for 2 years

AACR-AstraZeneca Fellowship for Translational Lung Cancer Research
Deadline: December 7, 2009, noon, Eastern Time
The AACR-AstraZeneca Fellowship for Translational Lung Cancer Research is open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects must relate directly to translational lung cancer research.   One 2-year grant of $90,000 ($45,000 per year) will be awarded. 
 
AACR Basic Cancer Research Fellowships
Deadline: December 7, 2009, noon, Eastern Time
The AACR Basic Cancer Research Fellowships are open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the 1st, 2nd, or 3rd year of their postdoctoral training at the start of the grant term. Proposed research projects may be in any area of basic cancer research. Three 1-year fellowships of $30,000-40,000 will be awarded. 
 
AACR Judah Folkman Fellowship for Anti-Angiogenesis Research
Deadline: December 7, 2009, noon, Eastern Time
The AACR Judah Folkman Fellowship for Anti-Angiogenesis Research is open to Postdoctoral and Clinical Research Fellows with a medical degree or a combined M.D./Ph.D. working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects are restricted to basic, clinical, translational or epidemiological projects that substantially advance the field of anti-angiogenesis research in cancer.  One 2-year grant of $90,000 ($45,000 per year) will be awarded. 
 
AACR Clinical and Translational Cancer Research Fellowships
Deadline: December 7, 2009, noon, Eastern Time.
The AACR Clinical and Translational Cancer Research Fellowships are open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects may be in any area of clinical and/or translational cancer research. One 1-year fellowship of $30,000 will be awarded.  

AACR Career Development Awards for Pediatric Cancer Research
Deadline: December 7, 2009, noon, Eastern Time.
The AACR Career Development Awards for Pediatric Cancer Research are open to junior faculty in their first full-time faculty appointment. Proposed research projects may be in any discipline of basic, clinical, translational, or epidemiological research with direct applicability and relevance to pediatric cancer. Two 2-year grants of $100,000 ($50,000 per year) for direct research expenses and salary support.

AACR-FNAB Career Development Award for Translational Cancer Research
Deadline: December 7, 2009, noon, Eastern Time.
The AACR-FNAB Career Development Award for Translational Cancer Research is open to junior faculty in their first full-time faculty appointment. Research projects are restricted to translational cancer research focused on any individualized therapeutic area.  Proposed projects must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. One 2-year grant of $100,000 ($50,000 per year) is available.

NIH Announcements:

Administrative Supplements for Disseminating Evidence-based Computer-tailored Cancer Control Interventions
(NOT-CA-10-003)
National Cancer Institute
Application Receipt Date(s): January 15, 2010
Funding: $150,000 in total costs for 1 year

Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21)
(RFA-CA-10-001)
National Cancer Institute
Application Receipt Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Funding: Standard R21 limits apply

Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)
(RFA-CA-10-002)
National Cancer Institute
Application Receipt Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Funding: Up to $300,000 in Direct Costs per year for 3 years

Application and Early Stage Development of Emerging Technologies in Cancer Research (R21)
(RFA-CA-10-003)
National Cancer Institute
Application Receipt Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Funding: Standard R21 limits apply

Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
(RFA-CA-10-004)
National Cancer Institute
Application Receipt Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Funding: Up to $300,000 in Direct Costs per year for 3 years

Innovative Technology Development for Cancer Research (R21)
(RFA-CA-10-005)
National Cancer Institute
Application Receipt Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Funding: Standard R21 limits apply

Enabling Technologies in DNA Repair Research (R21)
(PAR-10-016)
National Cancer Institute
Application Receipt Date(s): January 10, 2010
Funding: Standard R21 limits apply

Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)
(PAR-10-018)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard R21 limits apply.